Literature DB >> 21163179

Mortality of 2009 pandemic influenza A(H1N1) in Germany.

H Wilking1, S Buda, E von der Lippe, D Altmann, G Krause, T Eckmanns, W Haas.   

Abstract

The mortality in Germany caused by the 2009 pandemic influenza A(H1N1) seems to have been one of the lowest in Europe. We provide a detailed analysis of all 252 fatal cases of confirmed infection with the pandemic virus notified between 29 April 2009 and 31 March 2010. The overall mortality was 3.1 (95% confidence interval (CI): 2.7 to 3.5) per one million inhabitants. We observed an increase in the case fatality rate of notified cases over time; notified cases aged 60 years or older had the highest case fatality rate (2.16%; 95% CI: 1.61 to 2.83; odds ratio: 5.4; p<0.001; reference group: 35–59 years). The median delay of four days (interquartile range (IQR): 2–7) between symptom onset and antiviral treatment was significantly longer in fatal cases than for non-fatal cases (median: two days (IQR: 1–3; p<0.001). Analysis of the underlying medical conditions of fatal cases, based on the observed frequency of the conditions in the general population, confirms the risk for fatal outcome, which is most notably due to immunosuppression, diabetes and respiratory diseases. Our results suggest that early treatment might have had an impact on overall mortality. Identification of risk groups for targeted intervention to prevent fatalities needs to take into account the distribution of underlying conditions in the population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21163179     DOI: 10.2807/ese.15.49.19741-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  38 in total

1.  Antibody prevalence to the 2009 pandemic influenza A (H1N1) virus in Germany: geographically variable immunity in winter 2010/2011.

Authors:  Anne Hackenberg; Gökhan Arman-Kalcek; Jens Hiller; Gülsah Gabriel
Journal:  Med Microbiol Immunol       Date:  2012-06-10       Impact factor: 3.402

2.  Pandemic influenza A(H1)pdm09 in hospitals and intensive care units - results from a new hospital surveillance, Germany 2009/2010.

Authors:  Cornelia Adlhoch; Maria Wadl; Michael Behnke; Luis Alberto Peña Diaz; Jörg Clausmeyer; Tim Eckmanns
Journal:  Influenza Other Respir Viruses       Date:  2012-07-13       Impact factor: 4.380

Review 3.  Pandemic influenza: a never-ending story.

Authors:  Seiji Kageyama
Journal:  Yonago Acta Med       Date:  2011-09-01       Impact factor: 1.641

4.  Epidemiology of influenza A (H1N1)pdm09-associated deaths in the United States, September-October 2009.

Authors:  Joanna Regan; Ashley Fowlkes; Matthew Biggerstaff; Michael A Jhung; Jacqueline Gindler; Erin Kennedy; Victoria Fields; Lyn Finelli
Journal:  Influenza Other Respir Viruses       Date:  2012-07-16       Impact factor: 4.380

5.  Commentary: lessons learned from case fatality risk estimates of 2009 pandemic influenza.

Authors:  Gerardo Chowell; Cécile Viboud
Journal:  Epidemiology       Date:  2013-11       Impact factor: 4.822

6.  We should not be complacent about our population-based public health response to the first influenza pandemic of the 21st century.

Authors:  Heath A Kelly; Patricia C Priest; Geoffry N Mercer; Gary K Dowse
Journal:  BMC Public Health       Date:  2011-02-03       Impact factor: 3.295

7.  Mortality burden of the A/H1N1 pandemic in Mexico: a comparison of deaths and years of life lost to seasonal influenza.

Authors:  Vivek Charu; Gerardo Chowell; Lina Sofia Palacio Mejia; Santiago Echevarría-Zuno; Víctor H Borja-Aburto; Lone Simonsen; Mark A Miller; Cécile Viboud
Journal:  Clin Infect Dis       Date:  2011-10-05       Impact factor: 9.079

Review 8.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

Review 9.  Case fatality risk of influenza A (H1N1pdm09): a systematic review.

Authors:  Jessica Y Wong; Heath Kelly; Dennis K M Ip; Joseph T Wu; Gabriel M Leung; Benjamin J Cowling
Journal:  Epidemiology       Date:  2013-11       Impact factor: 4.822

Review 10.  COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.

Authors:  Cyril P Landstra; Eelco J P de Koning
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.